C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis

Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis

(2022) Emmanouil Bouras et al.   BMC Medicine

Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy Lifestyle

(2021) Meng Zhu et al.   CANCER RESEARCH

Circulating C‐reactive protein increases lung cancer risk: Results from a prospective cohort of UK Biobank

(2021) Mengmeng Ji et al.   INTERNATIONAL JOURNAL OF CANCER

Ageing-related markers and risks of cancer and cardiovascular disease: a prospective study in the EPIC-Heidelberg cohort

(2021) Bernard Srour et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Using Mendelian randomization to evaluate the causal relationship between serum C-reactive protein levels and age-related macular degeneration

(2020) Xikun Han et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Mendelian Randomization Analysis of Circulating Adipokines and C‐reactive Protein on Breast Cancer Risk

(2020) Timothy Robinson et al.   INTERNATIONAL JOURNAL OF CANCER

Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions

(2020) Francesca Arruga et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Gallstones, Body Mass Index, C‐reactive Protein and Gallbladder Cancer – Mendelian Randomization Analysis of Chilean and European Genotype Data

(2020) Carol Barahona Ponce et al.   HEPATOLOGY

Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer Risk

(2020) Chiyu He et al.   Frontiers in Oncology

A Linear and Non-Linear Mendelian Randomization Analysis of the Association Between Diastolic Blood Pressure and Cardiovascular Events: The J Curve Revisited

(2020) Marios Arvanitis et al.   CIRCULATION

Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium

(2019) David C Muller et al.   BMJ-British Medical Journal

High levels of C-reactive protein are associated with an increased risk of ovarian cancer: Results from the Ovarian Cancer Cohort Consortium

(2019) Lauren C Peres et al.   CANCER RESEARCH

The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study

(2019) Cilie C van’t Klooster et al.   EUROPEAN HEART JOURNAL

Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders

(2018) Symen Ligthart et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Mendelian randomization analysis of C-reactive protein on colorectal cancer risk

(2018) Xiaoliang Wang et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

The UK Biobank resource with deep phenotyping and genomic data

(2018) Clare Bycroft et al.   NATURE

Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization

(2017) James R. Staley et al.   GENETIC EPIDEMIOLOGY

Mendelian Randomization

(2017) Connor A. Emdin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Increased serum C-reactive protein levels are associated with shorter survival and development of second cancers in chronic lymphocytic leukemia

(2016) Yair Herishanu et al.   ANNALS OF MEDICINE

Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population

(2016) Kristine H. Allin et al.   INTERNATIONAL JOURNAL OF CANCER

Plasma C-Reactive Protein and Risk of Breast Cancer in Two Prospective Studies and a Meta-analysis

(2015) J. Wang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Cardiorespiratory fitness, C-reactive protein and lung cancer risk: A prospective population-based cohort study

(2015) Perfenia Paul Pletnikoff et al.   EUROPEAN JOURNAL OF CANCER

Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk

(2015) Marc J. Gunter et al.   JNCI-Journal of the National Cancer Institute

UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age

(2015) Cathie Sudlow et al.   PLOS MEDICINE

Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk

(2015) Marc J. Gunter et al.   JNCI-Journal of the National Cancer Institute

C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study

(2014) Laure Dossus et al.   CANCER CAUSES & CONTROL

Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels

(2011) Abbas Dehghan et al.   CIRCULATION

Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer

(2011) Kristine H. Allin et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Immunity, Inflammation, and Cancer

(2010) Sergei I. Grivennikov et al.   CELL

C-reactive protein-associated genetic variants and cancer risk: Findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies

(2010) Katriina Heikkilä et al.   EUROPEAN JOURNAL OF CANCER

C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study

(2010) Kristine H. Allin et al.   JNCI-Journal of the National Cancer Institute

Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer

(2009) Kristine H. Allin et al.   JOURNAL OF CLINICAL ONCOLOGY

C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies

(2008) Konstantinos K. Tsilidis et al.   INTERNATIONAL JOURNAL OF CANCER

The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine

(2008) P. Elliott et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY